Neurokinin 3 Receptor Antagonist [EPC]

2301 reported adverse events

Drugs of this class: FEZOLINETANT

These side effects are most commonly reported by patients taking drugs of the Neurokinin 3 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 281
1 HEPATIC ENZYME INCREASED 217
2 ALANINE AMINOTRANSFERASE INCREASED 200
3 ASPARTATE AMINOTRANSFERASE INCREASED 153
4 HEADACHE 130
5 OFF LABEL USE 124
6 NAUSEA 110
7 HOT FLUSH 107
8 LIVER FUNCTION TEST INCREASED 98
9 INSOMNIA 94
See all common reactions for Neurokinin 3 Receptor Antagonist [EPC]

Drugs of the Neurokinin 3 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FEMALE ORGASMIC DISORDER 2 0.0060
1 LIVER FUNCTION TEST INCREASED 98 0.0046
2 MENOPAUSAL SYMPTOMS 10 0.0043
3 DRUG-DISEASE INTERACTION 3 0.0041
4 ALANINE AMINOTRANSFERASE INCREASED 200 0.0033
5 HEPATIC ENZYME INCREASED 217 0.0032
6 ASPARTATE AMINOTRANSFERASE INCREASED 153 0.0029
7 FACIAL DISCOMFORT 2 0.0028
8 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
9 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
See all enriched reactions for Neurokinin 3 Receptor Antagonist [EPC]